Manufacturing

Articles

Catalent completes $4.6 million expansion at Singapore clinical supply facility and marks 20 years in the region.

Catalent Expands Clinical Supply Capabilities

Capsugel announced on Oct. 31, 2017 that it expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products using liquid-filled hard capsule technology, at its Edinburgh facility in Scotland.

Capsugel Expands Clinical Trial Services at UK Manufacturing Facility

The existing, obsolete highpurity water generation system and water-forinjection generation system were replaced with new, reliable technologies.

Case Study: Retrofitting Two New High-Purity Water Systems

The new suite will be used to produce non-sterile dosage forms, such as metered dose inhalers and semisolid topical products, for clinical studies up to Phase II.

Recipharm Opens New GMP Suite for Clinical Trial Materials

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

The company will begin trials with its CBD chewing gum, CanChew Plus, for the treatment of irritable bowel syndrome.

Axim Biotechnologies Begins Clinical Trials with CBD Chewing Gum

Catalent plans a $4.6 million investment to expand secondary packaging and storage in Asia.

Catalent Expands Singapore Clinical Trials Hub

Catalent’s Singapore facility is awarded GMP certification.

Catalent expands packaging capabilities in Singapore

Geographic location, customs and drug-development regulations knowledge, and transportation infrastructure were factors in Catalent Pharma Solutions' selection of Shanghai for its clinical-trials supply facility.

Clinical-Trial Material Supply by Way of Shanghai

ISPE&apos;s survey is industry&apos;s first large-scale effort to collect data on patient experiences with clinical trial materials.

ISPE Releases Report on Survey of Patient Experiences with Clinical Trial Materials

The authors examine risk management relating to the quality issues of clinical-trial materials and discuss areas that would benefit from additional consideration and harmonization.